|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$1,350
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-11
|
$22,965,613
|
$5,741,403
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$234,307
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
5P30CA016086-41
|
$7,114,974
|
$498,048
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$141,201
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$1,190,063
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
5P30CA068485-22
|
$5,853,094
|
$175,593
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
5P30CA014236-43
|
$5,679,062
|
$56,791
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$153,890
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-45
|
$5,113,872
|
$102,277
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$194,626
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
5P30CA016042-42
|
$4,295,192
|
$429,519
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$385,965
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$32,531
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$371,719
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Immunobiology for Marrow Allografts for Leukemia
|
5P01CA023766-38
|
$2,928,248
|
$204,977
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$264,558
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$52,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$50,488
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$73,400
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
OHSU Knight Cancer Institute
|
2P30CA069533-19
|
$2,310,000
|
$184,800
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Molecular Biology and Genetics of Human Tumor Viruses
|
5P01CA022443-40
|
$2,063,652
|
$1,093,736
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-38
|
$1,812,080
|
$1,812,080
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
5P01CA177322-04
|
$1,778,661
|
$1,689,728
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Early Events in KSVH Infection of Primary B-cells
|
5P01CA174439-05
|
$1,571,505
|
$1,571,505
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,554,465
|
$155,446
|
Raffeld, Mark
|
CCR (NCI)
|
|
KSHV Persistence and Pathogenesis
|
5P01CA180779-05
|
$1,472,214
|
$1,472,214
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
1P01CA214091-01
|
$1,356,357
|
$976,577
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$43,778
|
Barr, Frederic
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$1,000,515
|
$600,309
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-43
|
$980,728
|
$549,208
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Molecular Basis of KSHV oncogenesis
|
5R35CA200422-02
|
$958,770
|
$958,770
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
4R44CA206788-02
|
$939,552
|
$939,552
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$832,028
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Discovery and Characterization of New Human Cancer Viruses
|
5R35CA197463-02
|
$922,575
|
$461,288
|
MOORE, PATRICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-04
|
$875,813
|
$875,813
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
5R44CA192859-03
|
$866,508
|
$866,508
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
5R01CA206019-02
|
$816,487
|
$204,122
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-21
|
$794,238
|
$794,238
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-42
|
$789,141
|
$157,828
|
PAGANO, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
5R42CA153845-03
|
$772,615
|
$772,615
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
1U54CA221208-01
|
$731,876
|
$343,982
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-04
|
$688,290
|
$316,613
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
5U54CA190155-04
|
$680,763
|
$340,382
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
1U54CA221204-01
|
$670,280
|
$113,948
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$656,574
|
$65,657
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$621,630
|
$310,815
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Increasing HPV vaccine uptake in community-based pediatric practices
|
1R01CA207401-01A1
|
$608,628
|
$608,628
|
HULL, PAMELA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
Total relevant funding to Herpes - Other for this search: $50,074,340
|